Literature DB >> 21541901

Modulating effects of rooibos and honeybush herbal teas on the development of esophageal papillomas in rats.

Linda Sissing1, Jeanine Marnewick, Maryna de Kock, Sonja Swanevelder, Elizabeth Joubert, Wentzel Gelderblom.   

Abstract

Widespread consumption of herbal teas has stimulated interest in their role as cancer preventive agents. The present investigation monitored the modulation of methylbenzylnitrosamine (MBN)-induced esophageal squamous cell carcinogenesis by rooibos (Aspalathus linearis) and honeybush (Cyclopia intermedia) herbal and Camellia sinensis teas in male F344 rats. The tumor multiplicity was significantly (P < 0.05) inhibited by unfermented honeybush (45.5%), green (50%), and black (36%) teas, while the other teas exhibited weaker effects (<30% inhibition). The mean total papilloma size was reduced by unfermented rooibos (87%), unfermented honeybush (94%), and fermented honeybush (74%) due to the absence of large papillomas (>10 mm(3)). Reduction of the mean total papilloma number correlated with the total polyphenol (TPP) (r = 0.79; P < 0.02) and flavanol/proanthocyanidin (FLAVA) (r = 0.89; P < 0.008) intake (mg/100 g body weight) of the teas and the FLAVA (r = 0.89; P < 0.04) and flavonol/flavones/xanthones (r = 0.99; P < 0.002) intake when considering only the herbal teas. A daily TPP intake threshold of 7 mg/100 g body weight existed below where no inhibition of papilloma development was observed. Fermentation of herbal teas reduced the inhibitory effects on papilloma development associated with a reduction in the polyphenolic constituents. The inhibitory effect of herbal teas on papilloma development is associated with different flavonoid subgroups and/or combination thereof.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21541901     DOI: 10.1080/01635581.2011.539313

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  7 in total

Review 1.  Anti-ovarian cancer potential of phytocompound and extract from South African medicinal plants and their role in the development of chemotherapeutic agents.

Authors:  Chella Perumal Palanisamy; Bo Cui; Hongxia Zhang; Mani Panagal; Sivagurunathan Paramasivam; Uma Chinnaiyan; Selvaraj Jeyaraman; Karthigeyan Murugesan; Mauricio Rostagno; Vijayakumar Sekar; Srinivasa Prabhu Natarajan
Journal:  Am J Cancer Res       Date:  2021-05-15       Impact factor: 6.166

2.  Divide and Conquer May Not Be the Optimal Approach to Retain the Desirable Estrogenic Attributes of the Cyclopia Nutraceutical Extract, SM6Met.

Authors:  M Mortimer; K Visser; D de Beer; E Joubert; A Louw
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

3.  Mangiferin prevents guinea pig tracheal contraction via activation of the nitric oxide-cyclic GMP pathway.

Authors:  Aline B Vieira; Luciana P Coelho; Daniella B R Insuela; Vinicius F Carvalho; Marcelo H dos Santos; Patricia Mr Silva; Marco A Martins
Journal:  PLoS One       Date:  2013-08-08       Impact factor: 3.240

4.  Chemoprevention of LA7-Induced Mammary Tumor Growth by SM6Met, a Well-Characterized Cyclopia Extract.

Authors:  Omolola R Oyenihi; Annadie Krygsman; Nicolette Verhoog; Dalene de Beer; Michael J Saayman; Thys M Mouton; Ann Louw
Journal:  Front Pharmacol       Date:  2018-06-20       Impact factor: 5.810

5.  Rooibos herbal tea: An optimal cup and its consumers.

Authors:  Hannelise Piek; Irma Venter; Fanie Rautenbach; Jeanine L Marnewick
Journal:  Health SA       Date:  2019-02-21

6.  Protective Effects of Rooibos (Aspalathus linearis) and/or Red Palm Oil (Elaeis guineensis) Supplementation on tert-Butyl Hydroperoxide-Induced Oxidative Hepatotoxicity in Wistar Rats.

Authors:  Olawale R Ajuwon; Emma Katengua-Thamahane; Jacques Van Rooyen; Oluwafemi O Oguntibeju; Jeanine L Marnewick
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-18       Impact factor: 2.629

7.  Effects of consumption of rooibos (Aspalathus linearis) and a rooibos-derived commercial supplement on hepatic tissue injury by tert-butyl hydroperoxide in Wistar rats.

Authors:  B D Canda; O O Oguntibeju; J L Marnewick
Journal:  Oxid Med Cell Longev       Date:  2014-03-11       Impact factor: 6.543

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.